马鲁拉油纳米乳液通过减轻炎症和氧化应激来改善实验性帕金森症中的运动功能
Reem Alshaman1, Mona Qushawy2,3, Hatem I Mokhtar4
1Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia.
Frontiers in pharmacology
|December 20, 2023
概括
马鲁拉油纳米乳液有效降低了炎症和氧化应激,改善了帕金森病 (PD) 的小鼠模型中的运动功能. 这表明,纳米乳化马鲁拉油可能成为PD的新疗法.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,其特点是运动功能障碍,主要影响老年人.
- 玛鲁拉油 (M-Oil) 富含单不和脂肪酸和抗氧化剂,以其稳定性和用于化品和皮肤治疗而闻名.
- 实验性帕金森症模型对于理解疾病机制和测试潜在治疗方法至关重要.
研究的目的:
- 为了将马鲁拉油 (M-Oil) 制成一个油在水中的纳米乳液 (M-NE).
- 在帕金森病 (PD) 的实验模型中评估M-Oil和M-NE的抗炎和抗氧化作用.
- 在PD小鼠模型中评估M-NE对运动器官功能和神经炎症的影响.
主要方法:
- 在四个组的雄性白色老鼠中确定实验性帕金森症:载体,PD,PD + M-Oil和PD + M-NE.
- 使用开放场和气测试进行机车功能的评估.
- 在状组织样本中测量炎症标志物和氧化应激指标 (甲).
主要成果:
- 实验中患有PD的小鼠表现出运动性能受损,这种情况通过使用原始M-Oil和M-NE进行治疗而得到改善.
- 在PD组中,炎症标志物和恶意甲水平的升高被M-Oil和M-NE给药显著降低.
- 将M-Oil制成M-NE增强了其物理特性和生物活性.
结论:
- 马鲁拉油 (M-NE) 的纳米乳化增强了其抗炎和抗氧化特性.
- 在帕金森病的实验模型中,M-NE有效地缓解运动器官功能障碍并减少神经炎症.
- M-NE显示出作为治疗帕金森病症状管理的治疗剂的潜力.
相关概念视频
Parkinson's Disease: Treatment
274
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
274
Parkinson's Disease: Overview
554
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
554
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K


